Senior private markets executive and operator focusing on growth-stage technology and healthcare investments, with experience leading portfolio transformation, strategic M&A and capital markets execution. Matthew D. Copley brings cross-functional experience sourcing deals, driving operational improvements, and working with management teams to scale revenue and margins; known for active board involvement and structuring equity and debt financing to support expansion.
Senior private markets executive and operator focusing on growth-stage technology and healthcare investments, with experience leading portfolio transformation, strategic M&A and capital markets execution. Matthew D. Copley brings cross-functional experience sourcing deals, driving operational improvements, and working with management teams to scale revenue and margins; known for active board involvement and structuring equity and debt financing to support expansion.
Focuses on growth-stage technology and healthcare companies, prioritizing platform businesses with clear unit economics and scalable go-to-market models. Employs hands-on partnership with founders, combining operational playbooks, strategic M&A and tailored capital structures (equity and debt) to accelerate revenue and margin expansion. Investment decisions favor differentiated product-market fit, predictable recurring revenue, and governance arrangements enabling active board oversight. Balances growth orientation with disciplined downside protection—staging capital, performance-linked instruments and exit planning across three- to seven-year horizons.
Focuses on growth-stage technology and healthcare companies, prioritizing platform businesses with clear unit economics and scalable go-to-market models. Employs hands-on partnership with founders, combining operational playbooks, strategic M&A and tailored capital structures (equity and debt) to accelerate revenue and margin expansion. Investment decisions favor differentiated product-market fit, predictable recurring revenue, and governance arrangements enabling active board oversight. Balances growth orientation with disciplined downside protection—staging capital, performance-linked instruments and exit planning across three- to seven-year horizons.
| Trades 860 | Longs Won 546/860 63% | Profit Factor 5.83 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $194,550.09 |
| Average Win $69,794.07 | Best Trade (Mar 31) $2.76M | Sharpe Ratio -9.35 |
| Average Loss -$20,812.73 | Worst Trade (Oct 14) -$686,019.99 | Z-Score 1.46 (85.48%) |
| Commissions $0 | Avg. Trade Length 10m 3w | Expectancy $36,712.05 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 8,065 | 7,258 | 6,452 | 5,645 | 4,839 | 4,032 | 3,226 | 2,419 | 1,613 | 806 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 2,135 | $497,455 | $730,170 | - | $232,715 | 46.78% | -0.28% |
ABBV AbbVie Inc. | 1,092 | $213,294.35 | $309,401.82 | - | $96,107.47 | 45.06% | -0.051% |
AEP American Electric Power Company, Inc. | 2,003 | $225,337.76 | $248,952.87 | - | $23,615.11 | 10.48% | -1.459% |
AGGH Simplify Aggregate Bond ETF | 128,942 | $2.6M | $2.47M | - | -$135,388.96 | -5.21% | +0.473% |
ALL Allstate Corporation | 1,111 | $226,521.18 | $266,106.72 | - | $39,585.54 | 17.48% | +1.418% |
AMD Advanced Micro Devices, Inc. | 779 | $452,529 | $437,977.17 | - | -$14,551.83 | -3.22% | -1.505% |
AMGN Amgen Inc. | 747 | $223,668.87 | $324,212.94 | - | $100,544.07 | 44.95% | +1.856% |
AMZN Amazon.com Inc | 2,738 | $520,519.75 | $697,532.88 | - | $177,013.13 | 34.01% | +0.268% |
APH Amphenol Corporation | 4,704 | $207,352.32 | $383,281.92 | - | $175,929.6 | 84.85% | -1.463% |
ARE Alexandria Real Estate Equities, Inc. | 4,287 | $209,805.92 | $181,554.45 | - | -$28,251.47 | -13.47% | +2.048% |
ARW Arrow Electronics Inc. | 1,289 | $159,633.96 | $283,567.11 | - | $123,933.15 | 77.64% | -1.904% |
ASML ASML Holding N.V. New York Registry Shares | 179 | $191,504.94 | $296,681.76 | - | $105,176.82 | 54.92% | +0.451% |
AVDE Avantis International Equity ETF | 3,172 | $235,165.53 | $285,210.38 | - | $50,044.85 | 21.28% | +0.723% |
AVEM Avantis Emerging Markets Equity ETF | 2,343 | $160,589.17 | $211,760.34 | - | $51,171.17 | 31.86% | -0.703% |
AVGO Broadcom Inc. | 1,385 | $357,225.77 | $476,800.1 | - | $119,574.33 | 33.47% | -0.575% |
AZN AstraZeneca PLC American Depositary Shares | 1,419 | $279,854.95 | $236,575.68 | - | -$43,279.27 | -15.46% | +2.895% |
BAC Bank of America Corporation | 6,543 | $259,626.18 | $338,076.81 | - | $78,450.63 | 30.22% | +0.545% |
BIL SPDR Bloomberg 1-3 Month T-Bill ETF | 17,408 | $1.6M | $1.59M | - | -$2,469.87 | -0.15% | +0.011% |
BRK-B Berkshire Hathaway Inc. | 706 | $325,970.7 | $371,306.58 | - | $45,335.88 | 13.91% | -0.08% |
BUYW Main Buywrite ETF | 245,634 | $3.45M | $3.58M | - | $129,756.05 | 3.76% | 0.0 |